Crexendo (CXDO) Insider Notice: 8,200 Share Sale Scheduled on NASDAQ

Rhea-AI Filing Summary

Crexendo, Inc. (CXDO) Form 144 notifies of a proposed sale of 8,200 common shares by the reporting person, with an aggregate market value listed as $53,201. The shares were acquired by vesting of RSUs on 12/12/2021 and the intended sale is scheduled for 08/07/2025 on NASDAQ through Muriel Siebert & Co., Inc.

The filer also reported three recent sales in July 2025: 2,800 shares on 07/02/2025 for $18,211, 3,000 shares on 07/03/2025 for $19,436, and 1,000 shares on 07/07/2025 for $6,466. The person signing the notice represents no undisclosed material adverse information about the issuer.

Positive

• Shares to be sold were acquired via RSU vesting, indicating the transaction is monetization of compensation rather than a purchase-based liquidation
• Broker and planned sale date are disclosed, providing execution transparency (Muriel Siebert & Co.; 08/07/2025)

Negative

• Recent insider sales in July 2025 totaled 6,800 shares for aggregate gross proceeds of $44,113, which may be viewed negatively by some investors
• Form does not indicate a 10b5-1 trading plan adoption date, so sales may not be pursuant to a pre-established plan (no plan date disclosed)

Insights

Securities/Equity Analyst

TL;DR: Insiders plan modest sales of vested RSUs totaling 8,200 shares; recent July disposals indicate partial monetization, not necessarily material to company valuation.

The filing shows the 8,200 shares to be sold were originally acquired via RSU vesting on 12/12/2021 and are to be sold through a broker on NASDAQ. Recent July 2025 dispositions totaling 6,800 shares generated roughly $44,113 in gross proceeds. Relative to the reported outstanding share count of 30,169,531, the volumes disclosed are immaterial on a percentage basis, suggesting limited direct impact on share supply or valuation. The filing provides no new operational or financial data about the company.

Compliance/Risk Analyst

TL;DR: Notice appears procedurally complete: acquisition, payment type, past sales and broker are disclosed; signer affirms absence of undisclosed material information.

The form documents acquisition method (equity compensation via RSU vesting), broker details, planned sale date, and recent sales in the past three months, aligning with Rule 144 disclosure elements. There is an explicit signer representation regarding material adverse information, and no indications of incomplete mandatory fields within the provided content. The filing does not include additional attestations such as an adopted 10b5-1 plan date.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Muriel Siebert & Co., Inc., 653 Collins Ave, Miami Beach FL 33139	8200	53201.00	30169531	08/07/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/12/2021	Vesting of RSUs	Issuer			8200	12/12/2021	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	07/02/2025	2800	18211.00
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	07/03/2025	3000	19436.00
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	07/07/2025	1000	6466.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the CXDO Form 144?

The filing reports a proposed sale of 8,200 common shares by the reporting person, with an aggregate market value of $53,201, to be sold on 08/07/2025 on NASDAQ through Muriel Siebert & Co.

How were the 8,200 shares acquired according to the filing?

The shares were acquired by vesting of RSUs on 12/12/2021 and the payment/nature of acquisition is listed as Equity Compensation.

Has the reporting person sold any CXDO shares recently?

Yes. The filer reported three sales in July 2025: 2,800 shares on 07/02/2025 for $18,211; 3,000 shares on 07/03/2025 for $19,436; and 1,000 shares on 07/07/2025 for $6,466.

Does the filing state there is undisclosed material information about Crexendo?

The signer represents by signature that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.

Which broker is handling the planned sale of CXDO shares?

The planned sale is to be executed through Muriel Siebert & Co., Inc., 653 Collins Ave, Miami Beach FL 33139.